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In rat liver homogenates fortified with the appropriate cofactors (ATP and CoA), valproic acid induced H,02 production rates by far lower than 
those recorded on the straight medium-chain fatty acid n-octanoic acid. Using directly the CoA esters of these carboxylic acids as substrates for 
the rat liver H,O,-generating enzyme activities, valproyl-CoA, and n-octanoyl-CoA were found to induce similar oxidation rates. In the rat liver 
homogenates, cyanide-insensitive alproyl-CoA and octanoyl-CoA oxidations occurred at rates similar to those of valproyl-CoA and octanoyl-CoA 
oxidase(s), respectively. Studies on fractions obtained from rat liver postnuclear supernatants by isopycnic centrifugation on a linear sucrose density 
gradient disclose that the density distribution of valproyl-CoA oxidase superimposes to those of catalase, fatty acyl-CoA oxidase and cyanide- 
insensitive fatty acyl-CoA oxidation, three peroxisomal marker activities. By contrast, the cyanide-insensitive valproyl-CoA oxidation does not 
adopt the typical peroxisomal distribution of these activities but rather exhibits a mitochondrial ocalization with, however, a minor peroxisomal 
component. Interestingly enough, the comparative study of rat tissue distribution, inducibility by clofibrate and sensitivity to deoxycholate indicated 
that valproyl-CoA oxidase is an enzyme distinct from fatty acyl-CoA oxidase and bile acyl-CoA oxidase. Taken as a whole, the results presented 
here support the occurrence of a peroxisomal oxidation of the CoA ester of valproic acid and its d4-enoic derivate which might be characterized 
by two major features: initiation by an acyl-CoA oxidase distinct from fatty and bile acyl-CoA oxidases, and inability to complete thej3-oxidation 
cycle which would not proceed, at significant rates, further than the /I-hydroxyacyl-CoA dehydrogenation step in peroxisomes. 
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1. INTRODUCTION 
Acyl-CoAj?-oxidation in mammals takes place in two 
distinct cellular organelles: mitochondria and per- 
oxisomes (for a general consideration, see [l]). For a 
long time, /I-oxidation was thought to be the preroga- 
tive of mitochondria until the discovery in 1976 by La- 
zarow and de Duve [2] that peroxisomes also contain 
the enzymic equipment for catalysis of /?-oxidation. The 
initiating step of B-oxidation pathways is catalysed in 
mitochondria by various acyl-CoA dehydrogenases (3 
distinct straight-chain fatty acyl-CoA dehydrogenases 
with overlapping chain-length specificities and 2 distinct 
branched-chain acyl-CoA dehydrogenases [3]; and 1 
glutaryl-CoA dehydrogenase xhibiting both dehydro- 
genation and decarboxylation activities [4]). Specific or 
generalized deficiencies of these mitochondrial acyl- 
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CoA dehydrogenases have been recognised in human 
patients (for a general consideration, see [5]). 
In peroxisomes, it was initially thought that a single 
acyl-CoA oxidase existed with a broad substrate speci- 
ficity, a feature not further corroborated by enzyme 
purification studies or by peroxisomal acyl-CoA /I-oxi- 
dation activities either responsive or not to peroxisome 
proliferators [612]. In fact at least three distinct acyl- 
CoA oxidases have been demonstrated to occur in per- 
oxisomes: peroxisome proliferator inducible fatty acyl- 
CoA oxidase [6,7,10-121, bile acyl-CoA [6,7,10] and 
pristanoyl-CoA oxidases [11,12], the activity of the lat- 
ter two enzymes not being stimulated upon exposure to 
peroxisome proliferators. 
Previous evidence has been provided for the occur- 
rence of mitochondrial metabolism of valproic acid 
[ 13,141 initiated by 2-methyl-branched-chain acyl-CoA 
dehydrogenase [ 131. Interestingly, the data presented 
here might argue for the occurrence of an incomplete 
j?-oxidation of the CoA esters of valproic acid and re- 
lated metabolites in peroxisomes initiated by a medium 
branched-chain acyl-CoA oxidase which, on the basis 
of two criteria, sensitivity to deoxycholic acid and either 
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inducibility by fibrates or tissue distribution, is demon- 
strated to be distinct from fatty acyl-CoA oxidase and 
bile acyl-CoA oxidase. 
2. EXPERIMENTAL 
2.1. Materials 
Valproic acid metabolites including 2-propyl-pent-d4-enoic acid, 
2-propyl-4-hydroxy-pentanoic a id (2-propyl-4-methyl-y-butyrolac- 
tone) and 2-propyl-glutaric acid were gifts from Dr. Dricot, Labaz- 
Sanofi, Brussels. Valproic acid (2-propyl-pentanoic acid), 2-ethyl-hex- 
anoic acid, 2-methyl-hexanoic acid, and octanoic acid were purchased 
from Janssen Chimica (Beerse, Belgium). CoA, ATP and FAD were 
from Boehringer Pharma (Mannheim, Germany). Peroxidase type II, 
homovanilhc acid, glycylglycine buffer, octanoyl-CoA and lauroyl- 
CoA were from Sigma (St. Louis, MO, USA). 4-Methylumbelhferyl 
derivatives were from Koch-Light Laboratories (Colnbrook, Bucks, 
UK). Other common chemicals were of analytical grade from Merck 
(Darmstadt, Germany). 
2.2. Animals 
Adult male Wistar rats were used. They were fed on either a stand- 
ard laboratory animal chow (untreated animals) or a solid diet made 
by mixing the powdered animal chow with clofibrate (0.5% w/w) 
(clofibrate-treated animals). 
2.3. Chemical synthesis of CoA esters 
3a-, 7a-, 12a-Trihydroxy-5B-cholestanoic acid was purified from 
alligator bile [15], and its CoA ester (referred to as trihydroxy- 
coprostanoyl-CoA in the text) was synthesized according to the 
method of Webster and Killenberg [16]. CoA esters of valproic acid, 
2-propyl-pent-d4-enoic acid and 2-ethyl-hexanoic acid were synthe- 
sized essentially as previously described [17]. 
2.4. Enzyme assays 
Acyl-CoA oxidase activities were measured by fluorimetric detenni- 
nations of hydrogen peroxide production rates [ 181, using as substrates 
either the unesterified carboxyhc acid fortified with ATP and CoA 
(indirect assay) or the carboxylyl-CoA ester (direct assay). For the 
indirect assays, the assay medium (1 ml) contained 100 mM glycyl- 
glycine buffer, pH 8.3, 5 mM homovanillic acid, 0.1 mg horseradish 
peroxidase type II, 8 mM ATP, 6 mM MgCI,, 2 mM unesterified 
carboxylic acid as substrate and the homogenate proteins. For the 
direct assays, similar experimental conditions were utilized except hat 
neither ATP, MgCl, nor unesterified carboxylic acids were added, and 
0.2 mM acyl-CoA was included in the assay media. Cyanide-insensi- 
tive acyl-CoA oxidations were assayed using the procedure described 
by Lazarow [19]. 
Lysosomal j?-hexosaminidase and mitochondrial cytochrome c oxi- 
dase were measured as in previous work [20]. Sulphatase C activity 
was determined according to the procedure described in [21]. 
2.5. Rat liver homogenates 
Rat liver homogenates were routinely prepared in distilled water. 
In the case of cell fractionation studies (see below), the livers were 
homogenized in an isotonic medium buffered at pH 7.2-7.4 (see [22]). 
2.6. Cell fractionation 
Fractionation by density gradient equilibration was performed as 
previously described [22]. 
3. RESULTS 
3.1. Rat liver hydrogen peroxide-generating enzyme ac- 
tivities recorded on various unester$ed medium- 
chain carboxylic acids 
In a first series of experiments, various medium-chain 
96 
Ral liver acyl-CoA oxldase activity 










Fig. 1. Hydrogen peroxide production rates induced by various me- 
dium-chain carboxylates in rat liver postnuclear supernatants incu- 
bated with ATP and CoA. The oxidase activities are means + S.E.M. 
(n = 6) expressed as nmol hydrogen peroxide generated per min per 
mg of rat crude liver homogenate protein after subtraction of matched 
blank values which correspond to spontaneous hydrogen peroxide 
generation upon incubation of rat liver preparations with ATP and 
CoA. For other details. see section 2. 
carboxylic acids, including valproic acid and three re- 
lated metabolites (2-propyl-pent-A4-enoic acid 2-pro- 
pyl-4-hydroxy-pentanoic acid and 2-propyl-glutaric 
acid), as well as 2-ethyl-hexanoic acid, 2-methyl-hex- 
anoic acid and n-octanoic acid, were tested for their 
abilities to generate, when fortified with the appropriate 
cofactors, hydrogen peroxide upon incubation with rat 
liver homogenates. Under these conditions, optimal and 
minimal activities were recorded on n-octanoic and val- 
proic acids, respectively (Fig. I). The ACenoic derivate 
of valproic acid was by far a better substrate than val- 
proic acid, whereas other compounds displayed inter- 
mediary abilities as substrates (Fig. 1). 
3.2. Rat liver medium-chain acyl-coA oxidase activities 
In a second series of experiments, the CoA esters of 
valproic acid, 2-propyl-pent-A4-enoic acid and 2-ethyl- 
hexanoic acid, as well as octanoyl-CoA and lauroyl- 
CoA, were tested for their abilities to be substrates of 
rat liver acyl-CoA oxidases. As illustrated by Fig. 2, the 
optimal acyl-CoA oxidase activity was obtained on 2- 
propyl-pent-A4-enoyl-CoA and, under these conditions, 
roughly similar rates of hydrogen peroxide production 
were observed for the CoA esters of n-octanoic and 
valproic acids. Cyanide-insensitive acyl-CoA oxidation 
rates were of the same order of magnitude as the corre- 
sponding acyl-CoA oxidase activities (data not shown). 
3.3. Subcellular distribution of rat liver medium-chain 
acyl-CoA oxidase activities 
In a third series of experiments, the subcellular distri- 
bution of the medium-chain acyl-CoA oxidase activities 
were studied (Fig. 3). The valproyl-CoA oxidase activity 
displayed density distributions superimposable to those 
of fatty acyl-CoA oxidase, cyanide-insensitive fatty 
acyl-CoA oxidation and catalase (peroxisomes), and 
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clearly distinct from those of cytochrome c oxidase (mi- 
tochondria), sulphatase C (endoplasmic reticulum) and 
N-acetyl-/?-glucosaminidase (lysosomes). Strikingly, cy- 
anide-insensitive valproyl-CoA oxidation adopted a 
density distribution distinct from the peroxisomal 
marker enzymes. Rather, the optimal activities were 
recovered in the mitochondrial fractions with only a 
minor peroxisomal component (Fig. 3). In perosisome- 
enriched fractions, but not mitochondria, the cyanide- 
insensitive valproyl-CoA oxidation occurred at rates 
lower than valproyl-CoA oxidase-dependent H202 pro- 
duction (Table I). 
3.4. Other characteristics of medium-chain acyl-CoA 
oxidases 
The occurrence of a peroxisomal valproyl-CoA oxi- 
dase activity has raised the question of its analogy with, 
or distinction from, the other known peroxisomal acyl- 
CoA oxidases, especially fatty acyl-CoA oxidase and 
bile acyl-CoA oxidase. Table II compares the three ac- 
tivities, (valproyl-CoA, fatty acyl-CoA and bile acyl- 
CoA oxidase) in terms of rat tissue distribution and 
inducibility by a peroxisome proliferator. On the one 
hand, bile acyl-CoA oxidase is restricted to liver 
whereas the valproyl-CoA and fatty acyl-CoA oxidase 
activities occur in all the tissues studied (Table II). On 
the other hand, fatty acyl-CoA oxidase activity is stim- 
ulated by clofibrate, whereas valproyl-CoA and bile 
acyl-CoA oxidases are not (Table II). 
Fig. 4 compares the sensitivity to deoxycholate of 
these three activities. Each of these activities display a 
different sensitivity to increasing concentrations of the 
detergent. 
4. DISCUSSION 
The present work demonstrates the occurrence of an 





Fig. 2. Hydrogen peroxide production rates recorded upon incubation 
of rat liver postnuclear supernatants with various medium-chain acyl- 
CoAs. The oxidase activities are means f S.E.M. (n = 6) expressed as 
nmol hydrogen peroxide generated per min per mg of rat crude liver 
homogenate protein after subtraction of matched blank values which 
correspond to spontaneous hydrogen peroxide generation upon incu- 
bation of rat liver preparations without added ATP and CoA. 
DENSITY (g / cm)3 
Fig. 3. lsopycnic centrifugation of rat liver postnuclear supernatants. 
Subcellular localizations of valproyl-CoA oxidase and cyanide-insen- 
sitive valproyl-CoA oxidation are compared with (i) three peroxisomal 
marker activities (fatty acyl-CoA [lauroyl-CoA] oxidase, cyanide-in- 
sensitive fatty acyl-CoA [lauroyl-CoA] oxidation and catalase, and (ii) 
other subcellular markers, including cytochrome c oxidase (CYTOX), 
sulphatase C (SULPH. C) and N-acetyl-p-glucosaminidase 
(NABCase). Results are given as density distribution histograms. On 
the abscissa is the density span of the gradient divided into 15 sections 
of equal density increments (0.0167) from 1.05 to 1.30 g/cm’. On the 
ordinate is the frequency of enzymic activities in each section (Q/ 
ZQ.Ap, where Q is the amount of activity equilibrating within the 
section, ZQ the sum of the activities found in all subfractions, and Ap 
the density increment of the section). Density distributions typical of 
peroxisomal marker activities were found in the case of 2-propyl-pent- 
ACenoyl-CoA and 2-ethyl-hexanoyl-CoA H,O,-generating oxidase 
activities (data not shown). Recovery of enzyme activity in the sum 
of fractions was between 76 and 108%, with the exception of the 
recovery of cyanide-insensitive valproyl-CoA oxidation which was 
inferior to 35%. Other comments are in the text. PEROX, per- 
oxisomes; MITOS, mitochondria; ER, endoplasmic reticulum; 
LYSOS, lysosomes. 
acid and related metabolites. This medium branched- 
chain acyl-CoA oxidase appears to be located in 
peroxisomes and distinct from two other known per- 
oxisomal acyl-CoA oxidases: the fatty acyl-CoA oxi- 
dase inducible by peroxisome proliferators [6,8,10] and 
the bile acyl-CoA oxidase [6,8,10]. It may be stressed 
that this medium, branched-chain acyl-CoA oxidase 
shares apparently several properties with the pristanoyl- 
CoA oxidase recently described by the group of Man- 
naerts [11,12]: tissue distributions are not restricted to 
liver and no inducibilities by peroxisome proliferators 
have been recorded. It is, however, too early to conclude 
that the medium- (valproyl-CoA) and long- (pristanoyl- 
CoA) branched-chain acyl-CoA oxidase activities are 
expressed by a single protein. Taking into account that 
the pristanoyl-CoA oxidase upon purification displays 
straight-chain acyl-CoA oxidase activity (i.e. fatty acyl- 
CoA oxidase not inducible by peroxisome proliferators 
[12]), it might be questioned whether the valproyl-CoA 
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Table I 
Comparison between acyl-CoA oxidase and cyanide-insensitive acyl- 
CoA oxidation rates in mitochondria- and peroxisome-enriched frac- 
















The mitochondria- and peroxisome-enriched fractions refer to the 
fractions characterized by the higher content in cytochrome coxidase 
and sedimentable catalase activities, respectively. The results of acyl- 
CoA oxidase and cyanide-insensitive oxidation rates are expressed as 
nmol hydrogen peroxide and NADH, respectively, produced per min 
per mg protein. The values are the mean of three determinations made 
on the same liver samples obtained during the course of the cell 
fractionation experiment, the results of which in terms of enzyme 
activity density distributions are illustrated in Fig. 3. Essentially com- 
parable oxidation rates were obtained in mitochondria- and per- 
oxisome-enriched fractions collected during the course of one other 
cell fractionation experiment. 
oxidase activity is not a distinct enzyme, on the basis of 
the apparent absence of residual straight-chain acyl- 
CoA oxidase activity when the enzyme is assayed with 
concentrations of deoxycholate which completely abol- 
ish lauroyl-CoA oxidase activity (see Fig. 4). Future 
work is, therefore, required to establish firmly the anal- 
ogous or distinct nature of valproyl-CoA and pris- 
tanoyl-CoA oxidases. 
Another point is the fact that, to our knowledge, the 
known branched-chain acyl-CoA oxidoreductases, in- 
cluding mitochondrial isovaleryl-CoA and 2-methylbu- 
tyryl-CoA dehydrogenases [22,23], and peroxisomal 
bile acyl-CoA [6,7], pristanoyl-CoA [l l] and valproyl- 
CoA (this work) oxidases, are not inducible by per- 
oxisome proliferators. Interestingly enough, most of the 
metabolic pathways concerning these enzymes (cases of 
mitochondrial branched-chain acyl-CoA dehydroge- 
nases and peroxisomal bile acyl-CoA and most likely 
valproyl-CoA oxidase) involve a unique modified or 
classic /?-oxidation cycle and are not carnitine-depend- 
ent, even if the mitochondrial pathways are sensitive to 
carnitine, a property accounted for by the release of 
product inhibition of 2-oxoacid dehydrogenase, the rate 
limiting step in branched-chain amino acid metabolism 
(see [24]). In addition, these acyl-CoA oxidations occur 
in one compartment: isovaleryl-CoA and 2-methylbu- 
tyryl-CoA are not oxidized by peroxisomes [25], 
whereas bile acyl-CoA is not significantly oxidizable by 
mitochondria [6,26]. The mitochondrial oxidation of 
valproyl-CoA has been documented elsewhere [13,141. 
The pathway is initiated by mitochondrial branched- 
chain acyl-CoA dehydrogenase and proceeds up to 
/3-ketoacyl-CoA formation but not further [13,14]. In 
peroxisomes, the situation appears to be distinct, and/?- 
oxidation concerns the acyl-CoA oxidase step, mainly. 
The activity is impressive since it represents half of the 
activity recorded on lauroyl-CoA, which is classically 
referred to as the best substrate for peroxisomal 
/?-oxidation. In the case of peroxisomal handling of val- 
proyl-CoA, one might suggest hat the B-oxidation is 
incomplete, as may be inferred from the fact that cya- 
nide-insensitive valproyl-CoA oxidation activity is, in 
peroxisomal fractions, strongly rate-limiting for per- 
oxisomal acyl-CoA oxidase. Previous work failed to 
demonstrate the occurrence of a ,&hydroxyvalproyl- 
CoA dehydrogenase activity from peroxisomal origin 
[14], so that the cyanide-insensitive valproyl-CoA activ- 
ity recorded in the present work might be an artifact. 
Nevertheless, for the mitochondrial component of this 
Table II 
Rat tissue distribution and peroxisome proliferator inducibility of valproyl-CoA, fatty acyl-CoA and bile acyl-CoA oxidase activities 
Enzyme Substrate H,O,-generating oxidase activity* in rat tissues 
(A) Untreated animals 
Fatty acyl-CoA oxidase lauroyl-CoA 
Valproyl-CoA oxidase 2-propyl-pent-d4-enoyl-CoA 
Bile acyl-CoA oxidase trihydroxycoprostanoyl-CoA 
(B) Clofibrate-treated animals 
Fatty acyl-CoA oxidase lauroyl-CoA 
Valproyl-CoA oxidase 2-propyl-pent&l-enoyl-CoA 
Bile acyl-CoA oxidase trihydroxycoprostanoyl-CoA 
Liver Kidney cortex Intestinal mucosa Heart 
8.82 f 0.93 
9.47 f 1.03 
2.51 f 0.17 
95.4 f 11.5 
8.71 f 0.78 
2.11 + 0.14 
13.4 i: 0.8 2.15 + 0.13 0.21 f 0.02 
13.0 + 0.8 2.87 f 0.16 0.42 f 0.03 
no detectable no detectable no detectable 
activity activity activity 
34.5 + 2.3 7.51 f 0.86 1.77 + 0.08 
12.9 + 0.7 2.43 f 0.19 0.35 f 0.03 
no detectable no detectable no detectable 
activity activity activity 
*Expressed as nmol H202 /min/mg tissue (mean values f S.E.M.; n = 6). 
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Fig. 4. Comparative sensitivities of fatty acyl-CoA, bile acyl-CoA and 
valproyl-CoA oxidase activities to increasing concentrations of de- 
oxycholate. Essentially similar results were obtained in three other 
separate experiments. It may be stressed that results obtained with 
2-propyl-pent-d4-enoyl-CoA or 2-ethyl-hexanoyl-CoA oxidase activi- 
ties were comparable to those recorded on valproyl-CoA, whereas 
those monitored with octanoyl-CoA as a substrate superimposed to 
those of lauroyl-CoA oxidase activity (data not shown). 
activity, it may be stressed that mitochondrial /I-hy- 
droxyvalproyl-CoA dehydrogenase activity is operative 
in the assay conditions utilized in the measurement of 
cyanide-insensitive valproyl-CoA oxidation rates be- 
cause the mitochondrial activity is not sensitive to cya- 
nide and is supplemented with excess oxidized NAD. 
Concerning the peroxisomal component of cyanide-in- 
sensitive valproyl-CoA oxidation activity, two hypothe- 
ses may be retained: either contamination by mitochon- 
drial P-oxidation enzymes occurs, or peroxosimal 
/?-hydroxyvalproyl-CoA dehydrogenation is operative. 
In the latter case, the involvement of peroxisomal mem- 
brane-linked /Lhydroxyacyl-CoA dehydrogenase activ- 
ity must be evoked, the peroxisomal matrix enzyme 
being previously shown to be inactive on /?-hydroxyval- 
proyl-CoA [14]. 
On the other hand, it has previously been shown that 
valproate did not inhibit peroxisomal /I-oxidation and 
could induce increased hydrogen peroxide production 
in rat liver [27], a feature in agreement with the idea that 
valproic acid and related metabolites can be oxidized by 
peroxisomes. Finally, the present work provides the 
demonstration for a sequence of events responsible for 
the generation from 2-propyl-pent-A4-enoic acid of a 
2-propyl-pent-A2-A4-dienoic moiety, the toxicity of 
which has been the topic of other works [28,29]. The 
demonstrated sequence of reactions is the following: 
2-propyl-pent-A4-enoic acid + 2-propyl-pent-A4-enoyl- 
CoA + 2-propyl-pent-A2-A6dienoyl-CoA + H,O,, the 
first step occurring in the presence of ATP and CoA 
(mainly in the microsomal components, data not 
shown), and the second in peroxisomes. By analogy, 
one might mention, here, the formation of a glutaconoyl 
moiety in the unesterified form from glutaric acid, a 
pathway which proceeds according to a parallel se- 
quence of reactions: i.e. successive involvements of mi- 
crosomal dicarboxylyl-CoA synthetase [30] and per- 
oxisomal glutaryl-CoA oxidase [20,21]. 
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